Background: Patients with ectopic pregnancy and low serum β-HCG concentrations are commonly treated systemic methotrexate. Aim: To compare the outcome of methotrexate versus expectant management for females presenting pregnancy. Study design: Randomized controlled trial. Methodology: Females (n=140) were enrolled in study. Blood sample was taken beta-HCG noted. Then randomly divided two groups ...

BACKGROUND Approximately 15% of clinically recognized pregnancies end in miscarriage. The probabilities for successful outcome between expectant treatment and dilatation and curettage for management of many first-trimester incomplete spontaneous abortions are comparable. The goal of this study was to assess patient preferences for expectant treatment compared with dilatation and curettage, and ...

BACKGROUND European guidelines on fertility care emphasize that subfertile couples should receive information about their chances of a natural conception and should not be exposed to unnecessary treatments and risks. Prognostic models can help to estimate their chances and select couples with a good prognosis for tailored expectant management (TEM). Nevertheless, TEM is not always practiced. Th...

The management of early pregnancy loss used to be based largely in the hospital setting, but it has shifted to the outpatient setting, allowing women to remain under the care of their family physician throughout the miscarriage process. Up to 15 percent of recognized pregnancies end in miscarriage, and as many as 80 percent of miscarriages occur in the first trimester, with chromosomal abnormal...

This article describes and critically appraises clinical trials assessing misoprostol effectiveness in preventing primary postpartum haemorrhage (PPH) in home and community settings in low- and middle-income countries. Of 172 identified studies of misoprostol use in labour only six fulfilled the inclusion criteria. All trials used 600 μg misoprostol in the intervention arm; three assessed misop...